|
Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 3,685 USD | -0,94% |
|
+1,91% | -3,44% |
| 29/06 | Transcript : Larimar Therapeutics, Inc. - Special Call | |
| 29/06 | Larimar Therapeutics dépose le premier module de sa demande de licence biologique auprès de la FDA pour le nomlabofusp | MT |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0,94% | +1,91% | +2,48% | -23,83% | -3,44% | +16,42% | +14,25% | -64,66% | - | 388 M | |
| -0,84% | -5,68% | -0,89% | +6,25% | +5,25% | +56,84% | +72,39% | +195,03% | +5 529,85% | 54,49 Md | |
| +6,05% | +7,79% | +27,88% | +19,67% | +40,68% | +62,23% | +88,46% | -20,90% | - | 55,93 Md | |
| -1,25% | -5,69% | +12,76% | -25,11% | -36,86% | +6,83% | +430,89% | +299,76% | +863,99% | 23,87 Md | |
| -0,11% | -3,33% | -0,42% | -9,10% | -5,02% | -18,28% | -15,66% | -59,10% | - | 22,86 Md | |
| +3,51% | +10,88% | +27,88% | +6,86% | +25,76% | +44,84% | -3,21% | -71,29% | - | 20 Md | |
| +2,07% | +0,66% | +19,48% | +3,56% | -6,04% | +39,93% | -29,10% | -30,11% | +66,77% | 17,48 Md | |
| -4,00% | -10,96% | +40,27% | +107,34% | +183,22% | +181,91% | +328,17% | +1 580,55% | +601,13% | 15,39 Md | |
| +7,69% | +11,91% | +27,98% | +3,37% | +36,79% | +50,03% | +720,96% | - | - | 15,19 Md | |
| -0,52% | -0,79% | +5,03% | +25,71% | +27,00% | +26,34% | +190,07% | +219,73% | +559,54% | 14,02 Md | |
| +0,07% | -4,61% | +7,92% | +4,01% | -7,38% | +73,35% | +141,83% | +470,26% | - | 12,38 Md | |
| +0,03% | -0,92% | +10,01% | -26,40% | -11,12% | -36,19% | +623,02% | +121,12% | +105,90% | 12,01 Md | |
| +7,98% | +7,25% | +15,84% | -29,78% | -8,41% | -14,25% | +182,02% | +73,51% | - | 11,26 Md | |
| -0,32% | -3,89% | +14,29% | +24,80% | +28,39% | +114,63% | +141,29% | +322,26% | +724,87% | 11,12 Md | |
| -2,20% | -17,83% | -8,68% | -0,70% | +6,12% | +299,60% | +103,03% | +11,56% | +1 112,56% | 10,13 Md | |
| +0,02% | +0,15% | +0,58% | +18,03% | +23,23% | +46,54% | +199,13% | - | - | 9,83 Md | |
| +4,24% | +3,24% | +19,20% | -27,30% | +19,44% | +23,21% | +100,47% | -21,82% | - | 9,25 Md | |
| +0,20% | +0,47% | +138,84% | +110,91% | +80,19% | +163,52% | +320,24% | +325,57% | - | 8,83 Md | |
| -0,40% | +3,23% | +17,83% | +42,75% | +200,61% | +543,24% | +556,53% | -43,81% | -12,85% | 8,7 Md | |
| -0,52% | -4,58% | +13,03% | -7,33% | +21,41% | +58,79% | +17,54% | +173,40% | - | 8,12 Md | |
| Moyenne | +0,96% | -1,06% | +19,56% | +11,19% | +30,99% | +86,98% | +209,12% | +193,39% | +1 061,31% | 17,06 Md | |
| Moyenne pondérée par Capi. | +1,45% | -0,52% | +17,46% | +11,05% | +25,86% | +69,73% | +180,28% | +177,70% | +2 157,28% |
- Bourse
- Actions
- Action LRMR
- Secteur Larimar Therapeutics, Inc.
Choisissez Zonebourse Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
